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The intention of this review is to provide an overview of the potential role of neutrophil
extracellular traps (NETs) in mammalian reproduction. Neutrophil NETs appear to be
involved in various stages of the reproductive cycle, starting with fertility and possibly
ending with fetal loss. The first suggestion that NETs may play a role in pregnancy-related
disorders was in preeclampsia, where vast numbers were detected in the intervillous
space of affected placentae. The induction of NETosis involved an auto-inflammatory
component, mediated by the increased release of placental micro-debris in preeclampsia.
This report was the first indicating that NETs may be associated with a human pathology
not involving infection. Subsequently, NETs have since then been implicated in bovine or
equine infertility, in that semen may become entrapped in the female reproductive tract
during their passage to the oocyte. In this instance interesting species-specific differences
are apparent, in that equine sperm evade entrapment via expression of a DNAse-like
molecule, whereas highly motile bovine sperm, once free from seminal plasma (SP) that
promotes interaction with neutrophils, appear impervious to NETs entrapment. Although
still in the realm of speculation it is plausible that NETs may be involved in recurrent fetal
loss mediated by anti-phospholipid antibodies, or perhaps even in fetal abortion triggered
by infections with microorganisms such as L. monocytogenes or B. abortus.
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INTRODUCTION
Polymorphonuclear neutrophils (PMNs) are the most prevalent
leucocyte cell type in the peripheral circulation. They are char-
acterized by a uniquely lobulated nuclear structure and a highly
granulated cytoplasm. PMNs play a leading role in combatting
infection either by phagocytosis or by the release of antibacte-
rial granules (Nathan, 2006). A more recent attribute of these
cells is their ability to extrude their DNA into the extracellular
environment, as so-called neutrophil extracellular traps (NETs),
which serve to ensnare and kill bacteria (Brinkmann et al., 2004;
Brinkmann and Zychlinsky, 2007). This unique form of cell death
termed NETosis has been shown to be highly reliant on the action
of nicotinamide adenine dinucleotide phosphate (NADPH) oxi-
dase, the generation of reactive oxygen species (ROS) (Fuchs et al.,
2007), and the combined actions of myeloperoxidase (MPO),
neutrophil elastase (NE) (Papayannopoulos et al., 2010), and
histone deamination by human peptidylarginine deiminase 4
(PAD4) (Neeli et al., 2008; Wang et al., 2009). It is this facet which
forms the basis of this review.
PMNs are involved in several stages in the reproductive
cycle. In many mammalian species, PMNs have been implicated
Abbreviations: FRT, female reproductive tract; PMN, polymorphonuclear neu-
trophil; MC, menstrual cycle; SP, seminal plasma; AI, artificial insemination; IUGR,
intra-uterine fetal growth restriction; NE, neutrophil elastase; aPL, antiphospho-
lipid antibodies; β2GPI, beta-2-glycoprotein I; PAR-2, protease-activated recep-
tor 2; ROS, reactive oxygen species.
in tissue remodeling during the oestrous cycle when the
endometrium adapts to be receptive for oocyte implantation
(Strzemienski, 1989; Wood et al., 2007).
In murine systems, the influx of PMNs into the vaginal vault
appears to play a crucial role in the continued progression of
the oestrous cycle, as their depletion via application of anti-
Gr-1 monoclonal antibodies leads to a blocking of the cycle in
diestrus (Sasaki et al., 2009). This blockage was reversible, and
could be reverted by the re-introduction of circulatory PMNs into
affected mice. This neutropenic abrogation of the oestrous cycle
was accompanied by reduction in the levels of the sex hormones
oestradiol and progesterone, which are necessary for its main-
tenance, implying some form of feedback mediated by normal
endometrial presence of infiltrating PMNs. The feedback loop
was facilitated by opioid peptides released by activated PMNs,
which promote steroidogenesis by granulosa cells (Sasaki et al.,
2011).
During the human menstrual cycle (MC), large numbers of
PMNs have been noted in areas of tissue degradation (day 28)
prior to onset of menstruation (Salamonsen and Lathbury,
2000). It appears that endometrial PMNs may have different
phenotypes, as not all stained positive for metalloproteinase-9
(MMP-9) (Salamonsen et al., 2000). Endometrial PMNs have
also been determined to express ELAFIN, a serine protease
inhibitor and member of the whey acidic protein (WAP) fam-
ily (King et al., 2003a,b). Elafin is a potent inhibitor of NE
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and proteinase 3, and has been suggested to protect tissue
from degradation by these enzymes (King et al., 2003a,b). Since
Elafin has been demonstrated to possess anti-microbial activ-
ity, its presence could thereby contribute to innate immune
defence in the female reproductive tract (FRT) (King et al.,
2003a,b).
Hormonal changes occurring during the human MC have
also been shown to alter the physiology of circulating PMNs.
During the luteal phase of the MC, in which progesterone
peaks, a notable increase in circulatory PMNs numbers was
noted (Smith et al., 2007). Circulatory PMNs numbers remained
high until the onset of menstruation at day 28, at which time
they were still higher than those of comparable male donors.
During the luteal phase circulatory PMNs exhibited reduced
levels of MMP-9 and TNF-α expression (Smith et al., 2007).
During periods of oestrogen surges (week 2 and 3 of the MC),
circulatory PMNs in women expressed lower levels of CD89
(FcaR for IgA), CD11b, and CD18, which returned to normal
by week 4. In general, circulatory PMNs in women expressed
higher levels of CD89 than those from men (Smith et al.,
2007).
The reduction in expression of the integrins CD11b and CD18
could explain the diminution of neutrophil adhesion by oestro-
gen, and partially explain the anti-inflammatory action of this sex
hormone. The generally elevated expression of CD89 on periph-
eral PMNs by women indicates that they are more responsive to
activation via an IgA-based mechanism. Women mostly exhibit a
more robust humoral response than men.
In animal systems it is unclear if the oestrus cycle affects
circulatory and FRT-associated PMN pro-inflammatory activ-
ity. In hormone primed mares no change in the bactericidal
activity of circulatory PMNs was noted (Strzemienski et al.,
1987).
INTERACTION BETWEEN NEUTROPHILS AND SEMEN IN
THE FEMALE REPRODUCTIVE TRACT
During coitus billions of sperm are deposited into the FRT.
During the sexual act, microorganisms originating from either
the penis or the vagina are transported with the ejaculate either
into the vagina or directly into the uterus. In order to maintain an
environment favorable to implantation, these potential pathogens
need to be successfully eliminated. A further task is the removal
of the vast majority of sperm, as these can be antigenic to the
recipient female, and immunization against sperm can result in
infertility. A number of observations have shown that neutrophils
are recruited to the FRT following insemination in a manner
akin to inflammation, and that they play a major role in the
removal of excess sperm, largely via phagocytosis (Strzemienski,
1989; Alghamdi and Foster, 2005; Alghamdi et al., 2009; Katila,
2012).
Even though human reproductive tract leucocytosis has been
implicated in human infertility, interactions between neutrophils
and sperm have been best studied in large domesticated animals
such as cows and horses, due to the frequent use of artifi-
cial insemination (AI) for optimal breeding (Katila, 2012). In
these instances it has been observed that the repeated deposi-
tion of spermatozoa in the presence of neutrophils can lead to
diminished fertility (Alghamdi and Foster, 2005; Alghamdi et al.,
2009).
In early studies it was noted that bovine seminal plasma
(SP) reduced the ability of isolated PMNs to phagocytize bull
spermatozoa (Strzemienski, 1989). In further exploratory stud-
ies examining the action of SP it was evident that equine SP
contained factors that reduced neutrophil binding to spermato-
zoa in vitro (Alghamdi et al., 2004), thereby perhaps permitting
a greater number of healthy mobile spermatozoa to reach the
oviduct.
In these studies aggregates were noted between large num-
bers of PMNs and spermatozoa, which could be antagonized by
SP. The issue of these PMN-spermatozoa aggregates was subse-
quently addressed in more detail once it emerged that PMNs were
capable of producing extracellular traps (Brinkmann et al., 2004).
Since bovine SP was found to contain a fertility-promoting
factor with homology to DNAse I, the question was raised
whether such a factor would permit spermatozoa to evade the
presence of any PMN NETs in the FRT. In one of the first pub-
lications recording the presence of NETs in another system than
infection, Alghamdi and colleagues observed that the incubation
of isolated peripheral PMNs with equine spermatozoa lead to the
vigorous generation of NETs, with kinetics close to those medi-
ated by E. coli (Alghamdi and Foster, 2005). They furthermore
observed that the protein fraction of equine SP did indeed contain
amolecule with DNAse activity, as it was capable of digesting plas-
mid DNA, in a manner very similar to that performed by DNAse I
(Alghamdi and Foster, 2005).
The addition of this equine SP protein fraction to
spermatozoa-PMN mixtures led to the digestion of PMN
NETs, an aspect that could be partially mimicked by the addition
of extraneous DNAse I. It was, however, clear that equine SP
contains other factors that modulate PMNs response to sperma-
tozoa, as it reduced the number of NETs generated by accessory
PMNs in such cultures (Alghamdi and Foster, 2005) (Figure 1).
Of great interest is that equine SP protein fraction did not pre-
vent NETs induction by E. coli, nor did it prevent their killing by
activated PMNs. Of further note is that this equine DNAse-like
protein was virtually absent in the SP of a stallion with a record
of poor fertility. This strongly suggests that this factor assists in
mediating optimal interaction between spermatozoa and PMN
in the equine FRT, without compromising PMN bacteriocidal
activity (Alghamdi and Foster, 2005).
A major difference between bovine and equine insemination
is that in the former the spermatozoa are deposited in the vagina,
whilst in the latter they are ejaculated directly into the uterus
(Alghamdi et al., 2009; Katila, 2012). In bovines the sperma-
tozoa need to migrate through the cervix into the uterus, in
the process leaving most of the seminal fluid behind. Therefore,
the interaction between SP proteins modulating PMN activity
will be diminished in this case. Alternatively, in equines, SP
proteins could have a different function, because spermatozoa are
discharged adjacent to the site of fertilization.
This indeed turned out to be the case in that bovine SP medi-
ates a different modality on PMN activity than equine SP, by pro-
moting the binding of bovine spermatozoa to PMNs (Alghamdi
et al., 2009). On the other hand, in contrast to the situation in
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FIGURE 1 | Interaction between neutrophils and semen in the female reproductive tract. PMN can either phagocytize less motile spermatozoa or trap these
in NETs. The ability of PMNs to interact with spermatozoa is regulated largely by seminal plasma, which can promote NETting (bovine) or enhance escape (equine).
horses, bovine spermatozoa cleared completely of SP showed low
binding affinity to PMN, for a period as long as 3 h. This implies
that less mobile bovine spermatozoa will be ensnared by NETs
directly in the bovine vagina, due to the action of SP, while virile
highly motile spermatozoa will enter the uterus cleared of SP and
thereby evade interaction with any PMNs present in this part of
the FRT (Alghamdi et al., 2009).
Apart from demonstrating remarkable species-specific differ-
ences, these results have major implications in how AI is carried
out, and under which conditions SP protein fractions may have
beneficial character or not (Alghamdi et al., 2009; Katila, 2012).
OCCURRENCE OF NETs IN PREECLAMPSIA
Although the vast majority of human pregnancies progress to
term without any complications, many can be affected by dis-
orders such as fetal growth restriction, preeclampsia, or preterm
labor, which can result in maternal or fetal mortality/morbidity
(Wilkinson, 2011). To a large extent these different pathologies
may hold their origin in placental abnormalities (Brosens et al.,
2011).
Human placentation is unique by the depth of invasion of the
maternal endometrium by fetal tissues, but also by the extent in
which maternal blood vessels are modified by fetal trophoblast
(Huppertz, 2008; Pijnenborg et al., 2011). In this manner, toward
the end of the first trimester, extravillous trophoblast cells enter
the maternal endometrium and replace the endothelial cells of the
enlargement and relaxation of these vessels, thereby ensuring an
optimal blood flow though the intervillous space.
Failure of such a modification is associated with either
severe intra-uterine fetal growth restriction (IUGR) and/or early
onset preeclampsia (Redman and Sargent, 2005; Huppertz, 2008;
Brosens et al., 2011).
Preeclampsia is a disorder unique to human pregnancy,
characterized by proteinuria and sudden elevation in blood
pressure in previously normotensive pregnant women (Roberts
and Redman, 1993). Currently the only effective therapy is deliv-
ery of the baby, which frequently results in extreme prematurity,
as the onset of this disorder can occur as early as 20 weeks of
gestation. If left untreated, preeclampsia can develop into eclamp-
sia, a potentially lethal condition, characterized by epilepsy-like
convulsions (Roberts and Redman, 1993).
Even though the placenta plays a central role in the underlying
aetiology (Huppertz, 2008), preeclampsia is associated with sys-
temic damage of the maternal endothelium and an anomalous
maternal inflammatory response (Redman and Sargent, 2010).
This inflammatory response is mediated in part by the release
of placental micro-debris by the placental syncytiotrophoblast,
the deportation of which is elevated in cases with preeclamp-
sia (Gupta et al., 2005b; Hahn et al., 2005; Germain et al., 2007;
Messerli et al., 2010).
With regard to PMNs, previous studies have shown that nor-
mal human pregnancy is associated with a pro-inflammatory
phenotype of these cells, a feature which is significantly more pro-
nounced in preeclampsia (Sacks et al., 1998). This was reflected by
the elevated expression of cell surfaces markers such as CD11b,
but also intracellular activation markers, such as iROS (Sacks
et al., 1998). Additional evidence of peripheral PMN activation
under these conditions is provided by the presence of elevated lev-
els of NE in the plasma of patients with preeclampsia (Halim et al.,
1996; Gupta et al., 2006b). This activation appears to be stimu-
lated by the presence of placental micro-debris in the maternal
circulation (Aly et al., 2004).
Prompted by our observations that preeclampsia was asso-
ciated with significantly elevated fetal and maternal cell-
free DNA in the maternal circulation (Zhong et al., 2001b,
2005a,b), we were very intrigued by the report that PMNs can
release their nuclear DNA into the extracellular environment
(Brinkmann et al., 2004). Consequently, we set out to deter-
mine whether a possible connection existed between these two
phenomena.
For this purpose we used in vitro co-cultures using peripheral
PMNs isolated from healthy controls and highly purified placen-
tal micro-debris (Gupta et al., 2005a). In our experiments we
observed that placental micro-debris led to the activation of PMN
as assessed by the elevated expression of CD11b (Gupta et al.,
2005a). This activation by placental micro-debris was accompa-
nied by the generation of NETs, in a time and dose dependent
manner (Gupta et al., 2005a), with similar kinetics to what
had been previously observed using bacterial agents (Brinkmann
et al., 2004).
We also observed that NETs could be induced by other pla-
centally derived factors, such as the cytokine IL-8. It is therefore
possible that placentally derived micro-debris and inflammatory
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cytokines (IL-8) may act in concert in the activation of PMNs and
induction of NETs in pregnancy (Gupta et al., 2005a).
To assess whether these in vitro observations had any physi-
ological relevance we examined placentae from normal healthy
term deliveries or those affected by severe preeclampsia. PMN
NETs could be detected in the intervillous space of normal pla-
centae. This is to be expected as the normal placenta does deport
micro-debris, which could lead to PMNs activation and ensuing
NETosis, as part of the pro-inflammatory condition observed in
normal pregnancy. The number of NETs in preeclamptic placen-
tae was, however, dramatically elevated and appeared to fill the
entire intervillous space in certain instances.
As preeclampsia is characterized by hypoxia-reperfusion dam-
age (Burton and Jauniaux, 2004), the presence of large numbers of
NETs directly in the intervillous space, the site of oxygen exchange
between mother and fetus, may contribute to this.
Since NETs have recently been shown to promote thrombi in
deep vein thrombosis (DVT) and in tumor model systems (Brill
et al., 2012; Demers et al., 2012; Fuchs et al., 2012), it is possible
that the occlusion of blood flow through the intervillous space
by NETs could be exacerbated by such an additional event. The
likelihood of such an event is high, as excessive fibrin deposition
and infarction are frequently observed in preeclamptic placentae
(Kitzmiller and Benirschke, 1973).
PMN NETs may also contribute to the widespread systemic
damage to the maternal endothelium observed in preeclampsia
(Powe et al., 2011), since endothelial cells are susceptible to cell
death induced by NETting PMNs (Gupta et al., 2010).
Additional support suggesting that placentally derived fac-
tors contribute to PMN activation in preeclampsia is provided
by the study of circulatory PMNs isolated from maternal blood
isolated from the antecubital and uterine veins (Mellembakken
et al., 2002). In cases with preeclampsia, it was observed that
PMNs passing through the uteroplacental circulation appeared
to have a more highly activated phenotype than those present
in the peripheral circulation. No similar alteration was observed
in normal pregnancies. These data therefore suggest that an
inflammatory process occurs in the decidua and placental tissues
during the development of preeclampsia (Mellembakken et al.,
2002) (Figure 2).
It is currently unclear whether NETs represent an initiating
lesion in preeclampsia, or are the result of another underly-
ing placental deficiency. By using the data on maternal and
fetal cell-free DNA levels in preeclampsia, it may be possible
to tentatively infer regarding the time-point of NETs induction
(Gupta et al., 2006a). In this context, elevations in cell-free
fetal DNA have been suggested to be the result of a placen-
tal lesion, whilst elevations in maternal cell-free DNA could
result from the generation of NETs (Gupta et al., 2006a). A
number of studies have indicated that disturbances in cell-free
fetal DNA levels occur early in gestation, prior to the onset
of preeclampsia symptoms (Leung et al., 2001; Zhong et al.,
2001a). In contrast, cell-free maternal DNA is only elevated
once the symptoms become manifest (Zhong et al., 2001a).
These data imply that two phases are present in preeclampsia;
a pre-clinical phase involving a placental lesion, and a second
clinical phase with symptoms involving a systemic inflamma-
tory response by the mother (Roberts and Hubel, 2009). It
would, hence, appear that NETs are associated with the manifest
disorder, and not a preclinical initiating lesion (Gupta et al.,
2006a).
NETs also do not appear to distinguish between early and late
onset preeclampsia, as both seem to be associated with increased
PMNs activity as assessed by increased levels of NE in maternal
plasma in both forms, when compared to healthy pregnancies
(Gupta et al., 2006b).
Currently it is still not clear whether PMNNETs are involved in
other pregnancy-related disorders such as IUGR, recurrent fetal
loss or preterm labor (Hahn et al., 2006). It is also evident that
the underlying aetiology of multi-factorial syndromes, such as
preeclampsia, will not involve a single lesion, but rather involve a
number of different triggering events (Redman and Sargent, 2005;
Brosens et al., 2011). These may include the imbalance of placen-
tally produced angiogenic factors (Powe et al., 2011; Rana et al.,
2012), or the dysregulation of inflammatory cytokine networks
(Rusterholz et al., 2007; Granne et al., 2011).
A POSSIBLE ROLE OF NETs IN SPONTANEOUS FETAL LOSS
Although there is no direct evidence that NETs may be implicated
in fetal loss, induced either via the presence of autoantibodies
or infectious agents, there is accruing evidence that PMNs acti-
vation may play a crucial part in these events (Weiler, 2008;
Lynch and Salmon, 2010; Girardi, 2011). Recurrent fetal loss is
frequently associated with the presence of maternal antiphospho-
lipid antibodies (aPL) (Weiler, 2008; Lynch and Salmon, 2010;
Girardi, 2011). aPL via the interaction with beta-2-glycoprotein-
I (β2GPI), binds to phosphotidylserine moieties on the tro-
phoblast, thereby providing a key step for the activation of a series
of coagulation factors, hence, the layman’s term “sticky blood
syndrome.”
FIGURE 2 | Occurrence of NETs in preeclampsia. Large numbers of NETs have been detected directly in the intervillous space of preeclamptic placentae.
These NETs appear to be triggered by the elevated release of highly inflammatory placental micro-debris.
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The traditional view is that the presence of the aPL leads to
activation of the clotting cascade, thereby leading to placental
infarction and ensuing fetal demise (Weiler, 2008; Lynch and
Salmon, 2010; Girardi, 2011). Support for this notion is provided
by the clinical use of low molecular weight heparin, which has
been shown to be effective in preventing fetal loss in most cases
(Hahn et al., 2006).
Recent evidence indicating that aPL is associated with an
inflammatory activation of PMNs via the complement system is
leading to a change of the traditional dogma (Salmon andGirardi,
2008).
Evidence for such an interaction was largely provided by
murine model systems. It was determined that when aPL were
infused into pregnant mice, fetal demise was not associated with
a deposition of fibrin or increased presence of thrombi, but rather
that it involved the activation of the complement system, in par-
ticular components C3 and C5, and the repressive activity of
Crry (Holers et al., 2002; Girardi et al., 2003). In addition, the
innate arm of the immune system was implicated, as the decidua
of treated mice exhibited considerable PMNs infiltration and
elevated tissue factor (TF) expression (Redecha et al., 2007).
These findings were largely achieved via the dissection of
the underlying molecular pathways using a series of knock-out
murine models or pharmacologic inhibitors. In these examina-
tions it was determined that elevated TF expression by PMNs
appeared to be a crucial component in triggering fetal demise,
which was the result of a complex chain of events (Redecha et al.,
2007). The first of these was binding of aPL to the trophoblast,
thereby catalyzing zymogenic cleavage of C5. This permits the
active component C5a to bind to the C5aR on PMNs. This
receptor-ligand interaction triggers increased cell surface expres-
sion of TF, itself a receptor for coagulation factors FVIIa and
FXa. Such receptor TF/FVIIa-FXa complexes lead to activation
of the G-protein coupled protease-activated receptor 2 (PAR-2),
which in PMNs initiate ROS production and the release of
pro-inflammatory cytokines (Redecha et al., 2007; Weiler, 2008;
Girardi, 2011).
PMNs appear to be the final effector in this complement-
triggered cascade, as their depletion via the use of appropriate
antibodies effectively blocks aPL induced fetal loss (Pierangeli
et al., 2005). For this reason it was suggested aPL induced fetal loss
was the result of uncontrolled ROS production by complement
activated PMNs in the feto-maternal interface, leading to oxida-
tive damage of underlying placental tissue (Salmon and Girardi,
2008).
As the production of ROS is a vital component of the pathway
triggering NETosis and the release of DNA into the extracellular
environment (Fuchs et al., 2007), it is enticing to speculate that
NETs may occur in aPL induced fetal loss. Furthermore, as the
presence of NETs can be cytotoxic to closely adjacent cells (Gupta
et al., 2010), it is possible that the occurrence of such entities can
contribute to trophoblast injury apparent in this disorder.
An interesting observation is that PMNs from preterm infants
or neonates do not appear capable of undergoing NETosis, or
at least showed a very delayed response, when treated with
potent stimuli such as platelet activating factor (PAF) and
lipopolysaccharide (LPS), unlike normal adult PMNs (Marcos
et al., 2009; Yost et al., 2009). This facet did not appear to involve
a defect in signaling pathways, as neonatal PMNs expressed the
required receptors (PAF-R and TLR4) and displayed normal
responses, such as calcium mobilization, production of IL-8 in
response to these stimuli. This deficit could also not be overcome
by supplementation of intracellular ROS pools by treatment with
glucose/glucose oxidase. It is not clear from this particular study
how representative the relatively inert nature of neonatal PMN in
cases with preterm delivery is, since previous reports have sug-
gested that intrauterine activation of PMNs occurs under these
conditions, leading to pulmonary haemorrhage in affected infants
(Mehta and Petrova, 2006).
Although it may seem that the coagulation cascade is not
directly involved in this particular model system, since fetal loss
could not be hindered by anti-clotting agents such as hirudin,
which prevent thrombus formation but not complement acti-
vation, it may nevertheless play an accessory role. This would
especially be the case if NETs were implicated in aPL induced
fetal loss, as these could provide the necessary stimulus and scaf-
fold for clot formation (Fuchs et al., 2012). This supposition is
based on recent data indicating that NETs stimulate the extrin-
sic and intrinsic coagulation pathways, by promoting platelet and
RBC adhesion and by concentrating effector proteins and coag-
ulation factors involved in hemostasis (Fuchs et al., 2010, 2012;
Massberg et al., 2010; von Bruhl et al., 2012). In this context NETs
have been found to be abundant in experimental DVT in baboons
and mice, co-localizing with vWF, an important endothelial clot-
ting factor (Brill et al., 2012). Apart from providing a DNA-based
scaffold facilitating the binding of pro-coagulatory factors such as
Factor XII, intrinsic PMN derived serine proteases such as NE and
cathepsin G can stimulate clotting via the cleavage of coagulation
mediators such as tissue factor pathway inhibitor (TFPI), or fibrin
(Plow, 1980; Higuchi et al., 1992; Massberg et al., 2010; Semeraro
et al., 2011).
Given that preeclampsia, IUGR and even fetal loss are broadly
related to dysfunctions at the interface between innate immunity
and haemostasis, it would be of cardinal importance to investigate
the potential triggers of PMNs activation and NETosis in these
pathologies. The trigger could be the interaction of neutrophils
with activated cells, such as platelets or endothelium (Gupta et al.,
2010; Saffarzadeh et al., 2012), or alternatively, involve hypoxia,
inflammatory cytokines, or factors generated early in thrombotic
events (Fuchs et al., 2007).
The scope of PMN activity associated with fetal loss may, how-
ever, be even broader. This is based on recent data suggesting
that infections with Brucella abortis (Gupta and Bianchi, 1997)
or Listeria monocytogenes (Knowles et al., 2011) leads to PMNs
recruitment and activation, including release of IL-8 and ROS
production. As brucellosis in cattle or listeriosis in humans can
be directly associated with spontaneous abortion (Robbins and
Bakardjiev, 2012), it is open to speculation whether NETs occur
in infected placentae in these conditions, and thereby contribute
to the process of fetal loss (Figure 3).
CONCLUSIONS
The activity of PMNs is modulated or altered during various
phases of the reproductive cycle (Salamonsen and Lathbury, 2000;
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FIGURE 3 | A possible role of NETs in spontaneous fetal loss. In
murine models, fetal loss triggered by aPL involves activation of the
complement cascade, notably C3 and C5, which lead to PMNs
activation via TF. Ensuing ROS production is proposed to lead to
trophoblast damage, leading to fetal demise. It is not clear whether this
process involves NETosis or PMNs activation of the clotting cascade.
Wood et al., 2007; Sasaki et al., 2009). This is most evident in
the menstrual or oestrum cycle, in which the activity of cir-
culatory PMNs is altered by the action of sex hormones, but
also in the endometrial tissue, where PMNs play a role in tis-
sue removal or modification. PMNs appear to play a significant
role in post mating inflammatory response (Katila, 2012), as well
as in the trapping and clearance of sperm by NETs (Alghamdi
et al., 2004; Alghamdi and Foster, 2005). In these instances,
the action of seminal fluid reveals interesting species specific
differences, in that in horses it down-modulates PMN activity,
thereby promoting sperm escape, whereas in cattle it promotes
sperm entrapment by NETs (Alghamdi et al., 2004; Alghamdi and
Foster, 2005).
The presence of large numbers of NETs directly in the intervil-
lous space in preeclampsia (Gupta et al., 2005a), a crucial interface
between mother and fetus, as well as the induction of NETosis by
placentally-derived micro-vesicles or cytokines, suggest a role for
these entities in this enigmatic disorder (Gupta et al., 2007).
Although still in the realm of speculation, new evidence impli-
cating PMNs activation in fetal loss induced by auto-antibodies
(Salmon and Girardi, 2008) or infectious agents (Robbins and
Bakardjiev, 2012), may involve the occurrence of NETs.
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